Ivermectin Prophylaxis Used for COVID-19: A Citywide, Prospective, Observational Study of 223,128 Subjects Using Propensity Score Matching

Background: Ivermectin has demonstrated different mechanisms of action that potentially protect from both coronavirus disease 2019 (COVID-19) infection and COVID-19-related comorbidities. Based on the studies suggesting efficacy in prophylaxis combined with the known safety profile of ivermectin, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kerr, Lucy, Cadegiani, Flavio A, Baldi, Fernando, Lobo, Raysildo B, Assagra, Washington Luiz O, Proença, Fernando Carlos, Kory, Pierre, Hibberd, Jennifer A, Chamie-Quintero, Juan J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Infectious Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8765582/
https://www.ncbi.nlm.nih.gov/pubmed/35070575
http://dx.doi.org/10.7759/cureus.21272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8765582/
https://www.ncbi.nlm.nih.gov/pubmed/35070575
http://dx.doi.org/10.7759/cureus.21272

Ejemplares similares